Page last updated: 2024-12-08

celivarone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

celivarone: antiarrhythmic agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9807128
CHEMBL ID3707403
SCHEMBL ID3251183
MeSH IDM0483745

Synonyms (15)

Synonym
celivarone
401925-43-7
ssr 149744
celivarone [inn]
k45001587e ,
unii-k45001587e
5-benzofurancarboxylic acid, 2-butyl-3-(4-(3-(dibutylamino)propyl)benzoyl)-, 1-methylethyl ester
isopropyl 2-butyl-3-(4-(3-(dibutylamino)propyl)benzoyl)-1-benzofuran-5-carboxylate
CHEMBL3707403
ssr149744
SCHEMBL3251183
Q5058118
propan-2-yl 2-butyl-3-[4-[3-(dibutylamino)propyl]benzoyl]-1-benzofuran-5-carboxylate
SB17436
DTXSID50960620

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"In the MAIA trial, 673 patients with AF/AFL recently converted to sinus rhythm were randomly assigned to receive 50, 100, 200, or 300 mg once-daily dosing of celivarone; 200 mg daily of amiodarone preceded by a loading dose of 600 mg for 10 days; or placebo."( Celivarone for maintenance of sinus rhythm and conversion of atrial fibrillation/flutter.
Aliot, EM; Capucci, A; Connolly, SJ; Crijns, H; Hohnloser, SH; Khitri, AR; Kowey, PR; Kulakowski, P; Radzik, D; Roy, D, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's5 (41.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (33.33%)5.53%
Reviews4 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (33.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]